Cullen/Frost Bankers’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.67M | Sell |
66,530
-278,256
| -81% | -$15.1M | 0.04% | 230 |
|
|
2025
Q4 | $16.9M | Sell |
344,786
-26,341
| -7% | -$1.23M | 0.19% | 115 |
|
|
2025
Q3 | $16M | Sell |
371,127
-4,354
| -1% | -$170K | 0.19% | 111 |
|
|
2025
Q2 | $14.4M | Buy |
375,481
+16,999
| +5% | +$650K | 0.18% | 120 |
|
|
2025
Q1 | $13.9M | Buy |
358,482
+38,779
| +12% | +$1.42M | 0.19% | 117 |
|
|
2024
Q4 | $10.8M | Sell |
319,703
-94,436
| -23% | -$3.4M | 0.15% | 138 |
|
|
2024
Q3 | $16.9M | Buy |
414,139
+45,965
| +12% | +$1.88M | 0.23% | 109 |
|
|
2024
Q2 | $14.2M | Buy |
368,174
+46,852
| +15% | +$1.97M | 0.21% | 113 |
|
|
2024
Q1 | $13.8M | Buy |
321,322
+144,840
| +82% | +$5.97M | 0.2% | 127 |
|
|
2023
Q4 | $6.54M | Buy |
176,482
+9,777
| +6% | +$351K | 0.1% | 185 |
|
|
2023
Q3 | $6.04M | Buy |
166,705
+18,974
| +13% | +$673K | 0.11% | 180 |
|
|
2023
Q2 | $5.27M | Buy |
147,731
+25,340
| +21% | +$909K | 0.09% | 193 |
|
|
2023
Q1 | $4.35M | Buy |
122,391
+25,939
| +27% | +$907K | 0.08% | 199 |
|
|
2022
Q4 | $3.39M | Buy |
96,452
+36,128
| +60% | +$1.2M | 0.06% | 207 |
|
|
2022
Q3 | $1.78M | Buy |
60,324
+30,296
| +101% | +$1.15M | 0.04% | 232 |
|
|
2022
Q2 | $1.63M | Buy |
30,028
+20,351
| +210% | +$1.12M | 0.04% | 252 |
|
|
2022
Q1 | $527K | Sell |
9,677
-1,440
| -13% | -$78.2K | 0.01% | 383 |
|
|
2021
Q4 | $613K | Sell |
11,117
-3,273
| -23% | -$170K | 0.01% | 376 |
|
|
2021
Q3 | $687K | Sell |
14,390
-432
| -3% | -$21.7K | 0.01% | 351 |
|
|
2021
Q2 | $738K | Sell |
14,822
-4
| -0% | -$192 | 0.01% | 346 |
|
|
2021
Q1 | $661K | Sell |
14,826
-7,084
| -32% | -$322K | 0.01% | 351 |
|
|
2020
Q4 | $1.01M | Sell |
21,910
-4,975
| -19% | -$229K | 0.02% | 286 |
|
|
2020
Q3 | $1.26M | Buy |
26,885
+6,950
| +35% | +$348K | 0.03% | 253 |
|
|
2020
Q2 | $1.02M | Buy |
19,935
+1,470
| +8% | +$75.4K | 0.03% | 274 |
|
|
2020
Q1 | $875K | Sell |
18,465
-4,549
| -20% | -$243K | 0.03% | 263 |
|
|
2019
Q4 | $1.35M | Sell |
23,014
-1,235
| -5% | -$68.7K | 0.04% | 249 |
|
|
2019
Q3 | $1.29M | Buy |
24,249
+356
| +1% | +$18.3K | 0.04% | 246 |
|
|
2019
Q2 | $1.2M | Buy |
23,893
+439
| +2% | +$22K | 0.04% | 240 |
|
|
2019
Q1 | $1.23M | Buy |
23,454
+2,457
| +12% | +$123K | 0.04% | 231 |
|
|
2018
Q4 | $1M | Buy |
20,997
+3,092
| +17% | +$152K | 0.04% | 234 |
|
|
2018
Q3 | $899K | Buy |
17,905
+1,827
| +11% | +$92.8K | 0.03% | 246 |
|
|
2018
Q2 | $810K | Buy |
16,078
+371
| +2% | +$18.7K | 0.03% | 255 |
|
|
2018
Q1 | $767K | Buy |
15,707
+9,262
| +144% | +$431K | 0.02% | 263 |
|
|
2017
Q4 | $286K | Buy |
+6,445
| New | +$298K | 0.01% | 330 |
|
|
2017
Q1 | – | Sell |
-4,641
| Closed | -$223K | – | 373 |
|
|
2016
Q4 | $223K | Sell |
4,641
-128
| -3% | -$6.32K | 0.01% | 359 |
|
|
2016
Q3 | $258K | Buy |
4,769
+378
| +9% | +$20.7K | 0.01% | 338 |
|
|
2016
Q2 | $238K | Sell |
4,391
-1,205
| -22% | -$63.5K | 0.01% | 344 |
|
|
2016
Q1 | $283K | Sell |
5,596
-226
| -4% | -$11.3K | 0.01% | 326 |
|
|
2015
Q4 | $294K | Sell |
5,822
-1,108
| -16% | -$56.5K | 0.01% | 324 |
|
|
2015
Q3 | $333K | Buy |
6,930
+76
| +1% | +$3.96K | 0.01% | 305 |
|
|
2015
Q2 | $357K | Buy |
6,854
+76
| +1% | +$4.28K | 0.01% | 320 |
|
|
2015
Q1 | $391K | Sell |
6,778
-48
| -0.7% | -$2.75K | 0.01% | 316 |
|
|
2014
Q4 | $365K | Buy |
6,826
+1,912
| +39% | +$107K | 0.01% | 328 |
|
|
2014
Q3 | $282K | Buy |
4,914
+1,578
| +47% | +$96.7K | 0.01% | 335 |
|
|
2014
Q2 | $223K | Hold |
3,336
| – | – | 0.01% | 363 |
|
|
2014
Q1 | $223K | Buy |
+3,336
| New | +$226K | 0.01% | 361 |
|
Other funds holding GSK
JEST
